Global Biosimilars Market is Determined to Cross US$ 9.5 Billion By 2022

In this report, the global biosimilars market is segmented by product, application, and region. On the basis of product, the market is segmented into recombinant nonglycosylated proteins, recombinant peptides, and recombinant glycosylated proteins. The recombinant glycosylated proteins market is expected to witness the highest growth rate during the forecast period. On the basis of application, the market is segmented into oncology, blood disorders, growth hormone deficiency, chronic and autoimmune diseases, and infectious diseases. The market in the oncology segment is expected to witness the highest growth rate during the forecast period.

The global biosimilars market is expected to exceed US$ 9.5 billion by 2022, registering a compound annual growth rate (CAGR) of more than 26% during the forecast period.

A glimpse of the report structure is provided in the report description available on the website.
https://www.marketresearchengine.com/biosimilars-market-report

Sandoz International GmbH (Germany), Hospira, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Dr. Reddy’s Laboratories (India), Biocon Limited (India), Mylan, Inc. (U.S.), Amgen (U.S.), Celltrion Inc. (South Korea), Roche Diagnostics (Switzerland), and Merck KGaA (Germany) are the most active players in the biosimilars market.

The rising incidence of diseases, growing demand for biosimilar drugs due to their cost-effectiveness, increasing pressure to curtail healthcare expenditure, rising geriatric population, strategic collaborations resulting in enhanced productivity and clinical trial activities for biosimilars, and increasing government support and initiatives to develop and promote biosimilars are driving the market. However, the complexities in manufacturing and high costs, as well as innovative strategies by biologic drug manufacturers, are expected to hamper the growth of the market.

The Global Biosimilars Market has been segmented as below:

By Product Analysis
• Recombinant Nonglycosylated Proteins
• Recombinant Peptides
• Recombinant Glycosylated Proteins
•
By Application Analysis
• Oncology
• Blood Disorders
• Growth Hormone Deficiency
• Chronic and Autoimmune Diseases
• Infectious Diseases
•
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World

This report covers the biosimilars market, in terms of value, and forecasts the market size till 2022. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.

Request Sample Report: https://www.marketresearchengine.com/biosimilars-market-report

The deep-dive study on the biosimilars market will help customers with the identification of new market opportunities and targeted promotional plans.

Table of Contents

1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Biosimilars Market, By Type of Product
7 Biosimilars Market, By Type of Manufacturing
8 Biosimilars Market, By Application
9 Biosimilars Market, By Region
10 Competitive Landscape
11 Company Profiles
11.1 Introduction
11.2 Pfizer Inc.
11.3 Sandoz International GmbH (A Division of Novartis International AG)
11.4 Teva Pharmaceutical Industries Ltd.
11.5 F. Hoffmann-La Roche Ltd.
11.6 Amgen Inc.
11.7 Biocon Ltd.
11.8 Dr. Reddy's Laboratories
11.9 Celltrion Inc.
11.10 Mylan Inc.
11.11 Samsung Bioepis

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.